Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE3609.5529.6 (+0.83 %)

PREV CLOSE ( ) 3579.95

OPEN PRICE ( ) 3558.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2205

TODAY'S LOW / HIGH ( )3558.15 3639.25

52 WK LOW / HIGH ( )2891.45 3790

NSE3612.9033.8 (+0.94 %)

PREV CLOSE( ) 3579.10

OPEN PRICE ( ) 3581.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 3612.90 (88)

VOLUME 166143

TODAY'S LOW / HIGH( ) 3558.80 3639.00

52 WK LOW / HIGH ( )2886.45 3787.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1972

Management Info

Samir Mehta - Chairman Aman Mehta - Managing Director

Registered Office

Address Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

02Aug Torrent Pharmaceuticals informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure..

29Jul Torrent Pharmaceuticals soars on repor
Torrent Pharmaceuticals is currently trading at Rs. 3708.00, up by 83.05..

28Jul Torrent Pharmaceuticals reports 20% ri
Torrent Pharmaceuticals a has reported result for first quarter ended Ju..

28Jul Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that the Board has at its meeting h..

21Jul Allotment of Debentures
Quarterly Results & Inter alia, will also consider the Issue of Unsecure..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	5510	18880
Gross Profit	7420	26100
Operating Profit	9740	36070
Net Sales	26160	96820

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Cohance Lifesciences (BSE) 1011.20 (9.54%)	M.Cap ( in Cr)38685.19
Procter&Gamble Healt (BSE) 6525.95 (0.94%)	M.Cap ( in Cr)10832.67
Haleos Labs (BSE) 1169.00 (4.52%)	M.Cap ( in Cr)353.42
Glaxosmithkline Phar (BSE) 2811.40 (1.48%)	M.Cap ( in Cr)47626.81
Caplin Point Lab (BSE) 2174.00 (1.76%)	M.Cap ( in Cr)16524.94

Shareholding Pattern

	PROMOTERS	68.31%
	NON-INSTITUTION	6.94%
	MUTUAL FUNDS/UTI	4.95%
	FI/BANKS/INSURANCE	1.62%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Pha...	5.41
LIC MF Healthcare F...	5.10
ICICI Pru Nifty Pha...	4.51
Nippon India Nifty ...	4.50
PGIM India Healthca...	4.08
ITI Pharma & Health...	4.03
HDFC Pharma and Hea...	3.83

Risk Disclosures on Derivatives

Smart Quotes

TORRENT PHARMACEUTICALS LTD.